4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001995218-25-000005
Chief Executive Officer sold 13,133 shares at an average $8.94 ($117,436)
- Chief Executive Officer acquired 33,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-15 | Grant or award : show line 1 in the form | +33,000 | 255,251 | D | ||
| 2025-10-17 | Sale : show line 2 in the form | −12,985 | $8.94 | $116,021 | 242,266 | D |
| 2025-10-17 | Sale : show line 3 in the form | −148 | $9.56 | $1,415 | 242,118 | D |
| Open-market sales · 13,133 sh · avg $8.94 · $117,436 | ||||||
Loading xslF345X05/form4-10172025_111000.xml…